Skip to main content
. 2005 Dec 9;6(1):144. doi: 10.1186/1465-9921-6-144

Table 6.

The incidence of respiratory symptoms as reported by symptom diary during 7 days following challenge for the safety population

Symptom / beta2agonist use Mannitol Hypertonic Saline
n 627 (%) 636 (%)
Daytime cough 352 (56.9) 365 (58.4)
Wheeze 270 (43.6) 280 (44.8)
Trouble breathing 270 (43.6) 262 (41.9)
Symptoms interfering with activities 172 (27.8) 178 (27.4)
Night time cough 212 (34.2) 236 (37.8)
Beta2 agonist use 319 (51.5) 333 (53.3)
Nebulised beta2 agonist 16 (2.6) 19 (3.0)